Justin J. Mc Anear 10x Genomics, Inc. (TXG) insider trading activity

Justin J. Mc Anear is of 10x Genomics, Inc.. Currently has a direct ownership of 143,242 shares of TXG, which is worth approximately $3.29 Million. The most recent transaction as insider was on Aug 22, 2024, when has been sold 2,961 shares (Class A Common Stock) at a price of $22.53 per share, resulting in proceeds of $66,711. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 143K

2.03% 3M change

45.01% 12M change

Total Value Held $3.29 Million

Justin J. McAnear Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 22 2024	SELL Open market or private sale	$66,711 $22.53 p/Share	2,961 Reduced 2.03%	143,242 Class A Common Stock
May 22 2024	SELL Open market or private sale	$71,344 $24.3 p/Share	2,936 Reduced 1.97%	146,203 Class A Common Stock
Mar 21 2024	BUY Grant, award, or other acquisition	-	53,312 Added 26.41%	148,552 Class A Common Stock
Feb 22 2024	SELL Open market or private sale	$86,424 $46.34 p/Share	1,865 Reduced 1.92%	95,240 Class A Common Stock
Nov 22 2023	SELL Open market or private sale	$72,767 $43.34 p/Share	1,679 Reduced 1.7%	97,105 Class A Common Stock
Aug 22 2023	SELL Open market or private sale	$76,818 $45.78 p/Share	1,678 Reduced 1.67%	98,784 Class A Common Stock
May 23 2023	SELL Open market or private sale	$91,674 $55.06 p/Share	1,665 Reduced 1.63%	100,462 Class A Common Stock
Mar 21 2023	BUY Grant, award, or other acquisition	-	25,991 Added 20.38%	101,510 Class A Common Stock
Feb 22 2023	SELL Open market or private sale	$59,448 $47.75 p/Share	1,245 Reduced 1.62%	75,519 Class A Common Stock
Nov 22 2022	SELL Open market or private sale	$55,397 $34.07 p/Share	1,626 Reduced 2.07%	76,764 Class A Common Stock
Sep 14 2022	BUY Grant, award, or other acquisition	-	20,297 Added 20.57%	78,389 Class A Common Stock
Aug 23 2022	SELL Open market or private sale	$34,733 $35.19 p/Share	987 Reduced 1.67%	58,092 Class A Common Stock
May 23 2022	SELL Open market or private sale	$47,151 $48.76 p/Share	967 Reduced 1.61%	59,079 Class A Common Stock
May 13 2022	BUY Open market or private purchase	$6,397 $40.49 p/Share	158 Added 0.26%	60,046 Class A Common Stock
Mar 22 2022	BUY Grant, award, or other acquisition	-	21,357 Added 26.29%	59,888 Class A Common Stock
Feb 22 2022	SELL Open market or private sale	$22,637 $78.6 p/Share	288 Reduced 0.74%	38,531 Class A Common Stock
Jan 03 2022	SELL Open market or private sale	$1,470,500 $147.05 p/Share	10,000 Reduced 20.48%	38,819 Class A Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$50,400 $5.04 p/Share	10,000 Added 17.0%	48,819 Class A Common Stock
Dec 01 2021	SELL Open market or private sale	$1,500,800 $150.08 p/Share	10,000 Reduced 20.48%	38,819 Class A Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	$50,400 $5.04 p/Share	10,000 Added 17.0%	48,819 Class A Common Stock
Nov 22 2021	SELL Open market or private sale	$41,695 $148.38 p/Share	281 Reduced 0.72%	38,819 Class A Common Stock
Nov 01 2021	SELL Open market or private sale	$1,630,000 $163.0 p/Share	10,000 Reduced 20.37%	39,100 Class A Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$50,400 $5.04 p/Share	10,000 Added 16.92%	49,100 Class A Common Stock
Oct 01 2021	SELL Open market or private sale	$1,432,800 $143.28 p/Share	10,000 Reduced 20.37%	39,100 Class A Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$50,400 $5.04 p/Share	10,000 Added 16.92%	49,100 Class A Common Stock

JJM

Justin J. Mc Anear

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Value

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

Operation

Value

Type

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG

Account